Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 1, 1985Journal of Biological ChemistryOpen Access

Two mechanisms for inhibition of ADP-induced platelet shape change by 5'-p-fluorosulfonylbenzoyladenosine. Conversion to adenosine, and covalent modification at an ADP binding site distinct from that which inhibits adenylate cyclase.

View Full Paper
Ask AI
Bookmark
Share

Authors

DMD. C. B. MillsWFWR FiguresLSL. Marie Scearce

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Mills et al. (1985) studied this question.

synapsesocial.com/papers/6aa941ef03d7e8cf26cdc54ehttps://doi.org/10.1016/s0021-9258(17)39566-2
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Affinity labeling of a human platelet membrane protein with 5'-p-fluorosulfonylbenzoyl adenosine. Concomitant inhibition of ADP-induced platelet aggregation and fibrinogen receptor exposure.1981 · 56 citations
  2. 2Preparation of Suspensions of Washed Platelets from Humans1972 · 841 citations
  3. 3AFFINITY LABELING OF PURINE NUCLEOTIDE SITES IN PROTEINS1983 · 218 citations
  4. 4The influence on platelet aggregation of drugs that affect the accumulation of adenosine 3′:5′-cyclic monophosphate in platelets1971 · 425 citations
  5. 52-Methylthioadenosine[beta-32P]diphosphate. An agonist and radioligand for the receptor that inhibits the accumulation of cyclic AMP in intact blood platelets.1983 · 105 citations